SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma - Top-Institutions - MDSpire

SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma

  • By

  • Nicola Sgherza

  • Paola Curci

  • Rita Rizzi

  • Immacolata Attolico

  • Daniela Loconsole

  • Anna Mestice

  • Maria Chironna

  • Pellegrino Musto

  • December 14, 2021

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Immunology
    • Infectious Diseases

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy
    • Infectious Diseases

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Clinical Immunology

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Hematology
    • Infectious Diseases
    • Immunology

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

Original Source(s)

SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma

  • by Nicola Sgherza, Paola Curci, Rita Rizzi, Immacolata Attolico, Daniela Loconsole, Anna Mestice, Maria Chironna, Pellegrino Musto

  • December 14, 2021

Related Content

Rare COVID Vaccine Clotting Linked to Adenoviral Protein 

Antibody proteomics and immunogenetics identify adenoviral protein VII as the trigger of PF4-targeting antibodies 

  • April 21, 2026

  • 2 min
Acute liver failure and secondary TMA-like phenomenon following SARS-CoV-2 and Mycoplasma pneumoniae co-detection in a child: a case report

Infection risk associated with teclistamab in relapsed/refractory multiple myeloma: a systematic review and meta-analysis of clinical trial and real-world evidence